Retraction notice to “Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens” [Vaccine 32(35) (2014) 4428–4435] (Vaccine (2014) 32(35) (4428–4435), (S0264410X14008627), (10.1016/j.vaccine.2014.06.061));Modified Newcastle disease virus vectors expressing the H5 hemagglutinin induce enhanced protection against highly pathogenic H5N1 avian influenza virus in chickens

Vaccine

Volumn 32, Issue 35, 2014, Pages 4428-4435

  Kim, Shin Hee ^a   Paldurai, Anandan ^a   Xiao, Sa ^a   Collins, Peter L ^b   Samal, Siba K ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

H5N1 highly virulent avian influenza virus; Hemagglutinin; Newcastle disease virus; Vectored vaccine

Indexed keywords

HEMAGGLUTININ; HEMAGGLUTININ H5; HN PROTEIN; UNCLASSIFIED DRUG; VACCINE; VIRUS VECTOR; DRUG CARRIER; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHICKEN; CONTROLLED STUDY; GENE SEQUENCE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; INFLUENZA VIRUS A H5N1; MORTALITY; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; GENE VECTOR; GENETICS; IMMUNOLOGY; INFLUENZA IN BIRDS; NEWCASTLE DISEASE VIRUS; SURVIVAL;

ANIMALS; CHICKENS; DRUG CARRIERS; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; NEWCASTLE DISEASE VIRUS; SURVIVAL ANALYSIS;

EID: 84904393279     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2020.12.068     Document Type: Erratum

References (21)

1. Samal S.K. Newcastle disease and related avian paramyxoviruses. The biology of paramyxoviruses 2011, 69-114. Caister Academic Press. S.K. Samal (Ed.).
2. Alexander D.J. Newcastle disease. A laboratory manual for the isolation and identification of avian pathogens 1989, 114-120. The American Association of Avian Pathologists, Kendall/Hunt Publishing Company. 3rd ed. H.G. Purchase, L.H. Arp, C.H. Domermuth, J.E. Pearson (Eds.).
3. Huang Z., Elankumaran S., Yunus A.S., Samal S.K. A recombinant Newcastle disease virus expressing VP2 protein of infectious Bursal disease virus protects against NDV and IBDV. J Virol 2004, 78:10054-10063.
4. Nayak B., Rout S.N., Kumar S., Khalil M.S., Fouda M.M., et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS ONE 2009, 4:e6509.
5. DiNapoli J.M., Kotelkin A., Yang L., Elankumaran S., Murphy B.R., et al. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proc Natl Acad Sci U S A 2007, 104:9788-9793.
6. DiNapoli J.M., Yang L., Suguitan A., Elankumaran S., Dorward D.W., et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 2007, 81:11560-11568.
7. Bukreyev A., Huang Z., Yang L., Elankumaran S., St Claire M., et al. Recombinant Newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. J Virol 2005, 79:13275-13284.
8. Kim S.H., Nayak S., Paldurai A., Nayak B., Samuel A., et al. Complete genome sequence of a novel Newcastle disease virus strain isolated from a chicken in West Africa. J Virol 2012, 86:11394-11395.
9. Park M.S., Steel J., Garcia-Sastre A., Swayne D., Palese P. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci U S A 2006, 103:8203-8208.
10. Treanor J.J., Campbell J.D., Zangwill K.M., Rowe T., Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 2006, 354:1343-1351.
11. Krishnamurthy S., Huang Z., Samal S.K. Recovery of a virulent strain of Newcastle disease virus from cloned cDNA: expression of a foreign gene results in growth retardation and attenuation. Virology 2000, 278:168-182.
12. Huang Z., Krisnamurthy S., Panda A., Samal S.K. High-level expression of a foreign gene from the 3' proximal first locus of a recombinant Newcastle disease virus. J Gen Virol 2001, 82:1729-1736.
13. DiNapoli J.M., Nayak B., Yang L., Finneyfrock B.W., Cook A., et al. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 2010, 84:1489-1503.
14. Reed L.J., Muench H.A. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
15. Samuel A., Nayak B., Paldurai A., Xiao S., Aplogan G.L., et al. Phylogenetic and pathotypic characterization of Newcastle disease viruses circulating in west Africa and efficacy of a current vaccine. J Clin Microbiol 2013, 51(3):771-781.
16. Ge J., Deng G., Wen Z., Tian G., Wang Y., et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 2007, 81:150-158.
17. Veits J., Wiesner D., Fuchs W., Hoffmann B., Granzow H., et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci U S A 2006, 103:8197-8202.
18. Bukreyev A., Collins P.L. Newcastle disease virus as a vaccine vector for humans. Curr Opin Mol Ther 2008, 10:46-55.
19. DiNapoli J.M., Ward J.M., Cheng L., Yang L., Elankumaran S., Murphy B.R., et al. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine 2009, 27:1530-1539.
20. Bukreyev A., Skiadopoulos M.H., Murphy B.R., Collins P.L. Nonsegmented negative-strand viruses as vaccine vectors. J Virol 2006, 80:10293-10306.
21. Vigil A., Park M.S., Martinez O., Chua M.A., Xiao S., et al. Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus. Cancer Res 2007, 67:8285-8292.